Prevalence of targetable genomic alterations among a diverse population participating in the ASCO TAPUR Study
Abstract The Targeted Agent and Profiling Utilization (TAPUR) Study (NCT02693535, registered on February 23, 2016) is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancers harboring genomic alterations known to be drug t...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00962-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|